微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 0.65% | 550% | 200% | 31/142 | 4.9% | 三鑫医疗 | 13.46% | 行业排名> |
| 2026-06-30 | -0.65% | 24.42% | -190.28% | 103/142 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 0.72% | 84.62% | 122.15% | 74/142 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -3.25% | -52.58% | -3350% | 107/142 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 0.1% | -87.5% | 111.63% | 103/142 | 4.18% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -0.86% | -1333.33% | -320.51% | 111/142 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.39% | -66.67% | 118.31% | 92/142 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -2.13% | 82.18% | -366.25% | 108/142 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 0.8% | 116.77% | 1433.33% | 99/142 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -0.06% | 97.55% | -105.13% | 104/142 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.17% | 325% | 109.79% | 70/142 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -11.95% | -121.04% | -150.52% | 125/142 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | -4.77% | -109.07% | -94.69% | 119/142 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | -2.45% | -106.12% | -371.15% | 122/142 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | -0.52% | -102.35% | -100.92% | 110/142 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 56.8% | 4.68% | 7.98% | 5/142 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 52.6% | 8.52% | 31.43% | 6/142 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 40.02% | 50.9% | 80.84% | 5/142 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 22.13% | 6.14% | -59.21% | 9/142 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 54.26% | -5.26% | 11.95% | 9/142 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 48.47% | 1.96% | 82.77% | 7/142 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 26.52% | 3.88% | 27.19% | 8/142 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 20.85% | 115.84% | -63.59% | 7/142 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 57.27% | 207.9% | 20.47% | 16/142 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 47.54% | 247.51% | 86.21% | 9/142 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 25.53% | 207.59% | 164.29% | 18/142 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 9.66% | 2% | -48.06% | 5/142 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 18.6% | -2.46% | 35.96% | 44/142 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 13.68% | 2% | 64.82% | 18/142 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 8.3% | 2% | -56.48% | 23/142 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2018-12-31 | 19.07% | 52.19% | 52.19% | 35/142 | 14.23% | 新华医疗 | 13.55% | 行业排名> |
| 2017-12-31 | 12.53% | -7.87% | -7.87% | 55/142 | 14.51% | 安旭生物 | 48.71% | 行业排名> |
| 2016-12-31 | 13.6% | 2% | 2% | 42/142 | 16.44% | 迈瑞医疗 | 38.33% | 行业排名> |